EPAM Systems, Inc.’s stock price drops to $283.71, marking a 3.02% decrease: Is it time to buy?

EPAM Systems, Inc. (EPAM)

283.71 USD -8.84 (-3.02%) Volume: 1.1M

EPAM Systems, Inc.’s stock price stands at 283.71 USD, experiencing a dip of -3.02% this trading session with a trading volume of 1.1M shares, reflecting a year-to-date (YTD) percentage change of -4.58%.

Latest developments on EPAM Systems, Inc.

EPAM Systems has recently tied executive rewards to performance goals, indicating a strong focus on achieving key business targets. This strategic move combined with the company’s commitment to purchase EPAM Systems stock at $260, which is expected to earn an 8.3% annualized yield using options, has stirred significant interest among investors. Additionally, Guggenheim’s bullish outlook on EPAM Systems stock, based on a predicted recovery in tech demand, has further influenced positive price movements today.

EPAM Systems, Inc. on Smartkarma

Epam Systems, a global software engineering and IT consulting company, has been receiving significant analyst coverage on Smartkarma, an independent investment research network. According to analysts at Baptista Research, who have published multiple reports on the company, Epam had a challenging year in 2023 due to geopolitical factors such as the Russian invasion of Ukraine. Despite these challenges, Epam managed to perform well and demonstrate its ability to navigate a volatile demand environment. The company focused on enhancing delivery quality, cost effectiveness, and leveraging technological capabilities for future opportunities. Baptista Research evaluates various factors that could impact Epam’s price and conducts an independent valuation using a Discounted Cash Flow (DCF) methodology.

In another report, Baptista Research highlights Epam’s strong performance in the previous quarter, with an all-around beat in terms of revenue and earnings. However, the company’s exit from the Russian market had a negative impact on year-over-year revenue growth. Financial services also saw a decline, driven by decreases in banking, partially offset by growth in asset management. Baptista Research also conducts a fundamental analysis of Epam’s historical financial statements in this report.

Despite declining health and tech sectors, Epam Systems has maintained an unwavering focus, according to Baptista Research‘s analysis. The company exceeded analyst expectations with a reported revenue of $1.17 billion, a 2.1% year-over-year decline. Travel and consumer sectors saw a decline, primarily due to decreases in retail, offset by strong growth in travel and hospitality. Baptista Research‘s report provides a comprehensive analysis of Epam’s historical financial statements, giving investors valuable insights into the company’s performance.

A look at EPAM Systems, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Epam Systems, a company that provides software development and outsourcing services, has received an overall outlook score of 3 out of 5 from Smartkarma Smart Scores. This score is based on various factors such as value, dividend, growth, resilience, and momentum. While the company has scored a respectable 3 in value and growth, it has received a lower score of 1 in dividends. However, the company has received a high score of 4 in both resilience and momentum, indicating a strong and stable outlook for the future.

According to Smartkarma Smart Scores, Epam Systems, a software development and outsourcing company, has a positive long-term outlook. With an overall score of 3 out of 5, the company has performed well in terms of value and growth. However, it has received a lower score of 1 in dividends. On the other hand, the company has received a high score of 4 in both resilience and momentum, indicating a strong and stable outlook for the future. This positive outlook suggests that Epam Systems is a company worth keeping an eye on in the long run.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma